JP2016518458A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518458A5
JP2016518458A5 JP2016514478A JP2016514478A JP2016518458A5 JP 2016518458 A5 JP2016518458 A5 JP 2016518458A5 JP 2016514478 A JP2016514478 A JP 2016514478A JP 2016514478 A JP2016514478 A JP 2016514478A JP 2016518458 A5 JP2016518458 A5 JP 2016518458A5
Authority
JP
Japan
Prior art keywords
nitrite
hydrogel
layer
polymer
copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016514478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518458A (ja
JP6446035B2 (ja
Filing date
Publication date
Priority claimed from GB201309092A external-priority patent/GB201309092D0/en
Application filed filed Critical
Publication of JP2016518458A publication Critical patent/JP2016518458A/ja
Publication of JP2016518458A5 publication Critical patent/JP2016518458A5/ja
Application granted granted Critical
Publication of JP6446035B2 publication Critical patent/JP6446035B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016514478A 2013-05-20 2014-05-20 経皮的デリバリーシステム Active JP6446035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201309092A GB201309092D0 (en) 2013-05-20 2013-05-20 Transdermal delivery system
GB1309092.3 2013-05-20
PCT/GB2014/051544 WO2014188175A1 (en) 2013-05-20 2014-05-20 Transdermal delivery system

Publications (3)

Publication Number Publication Date
JP2016518458A JP2016518458A (ja) 2016-06-23
JP2016518458A5 true JP2016518458A5 (cg-RX-API-DMAC7.html) 2017-07-06
JP6446035B2 JP6446035B2 (ja) 2018-12-26

Family

ID=48747065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016514478A Active JP6446035B2 (ja) 2013-05-20 2014-05-20 経皮的デリバリーシステム

Country Status (18)

Country Link
US (1) US10010648B2 (cg-RX-API-DMAC7.html)
EP (1) EP2908873B1 (cg-RX-API-DMAC7.html)
JP (1) JP6446035B2 (cg-RX-API-DMAC7.html)
CN (1) CN105431175B (cg-RX-API-DMAC7.html)
AU (1) AU2014270116B2 (cg-RX-API-DMAC7.html)
DK (1) DK2908873T3 (cg-RX-API-DMAC7.html)
ES (1) ES2658037T3 (cg-RX-API-DMAC7.html)
GB (1) GB201309092D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20180079T1 (cg-RX-API-DMAC7.html)
HU (1) HUE035847T2 (cg-RX-API-DMAC7.html)
LT (1) LT2908873T (cg-RX-API-DMAC7.html)
NO (1) NO2908873T3 (cg-RX-API-DMAC7.html)
PL (1) PL2908873T3 (cg-RX-API-DMAC7.html)
PT (1) PT2908873T (cg-RX-API-DMAC7.html)
RS (1) RS56833B1 (cg-RX-API-DMAC7.html)
SI (1) SI2908873T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800030T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014188175A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
GB201520990D0 (en) * 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
TWI605843B (zh) * 2016-12-21 2017-11-21 嘉藥學校財團法人嘉南藥理大學 氣相經皮吸收系統
WO2019166572A1 (en) 2018-02-28 2019-09-06 Pharming Intellectual Property B.V. Pharmaceutical system for transdermal administration of a c1 -esterase inhibitor
US12220493B2 (en) 2018-07-16 2025-02-11 Systagenix Wound Management, Limited Nitric oxide producing collagen/ORC dressing
AU2020211392A1 (en) * 2019-01-11 2021-07-22 Noxsano Inc. Electrochemical gasotransmitter generating compositions and bimetallic cells for the generation of gasotransmitters
JP7686578B2 (ja) * 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
BR112021023832A8 (pt) 2019-06-04 2023-02-28 Thirty Holdings Ltd Métodos e composições para geração de óxido nítrico e usos dos mesmos
GB2609799B (en) * 2020-04-02 2025-05-28 Smith & Nephew Wound dressing
GB202004868D0 (en) * 2020-04-02 2020-05-20 Smith & Nephew Wound care compositions and methods of preparation thereof
AU2021259360A1 (en) 2020-04-23 2022-12-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating SARS-CoV and SARS-CoV-2
CN115768413B (zh) 2020-04-23 2025-10-24 三十呼吸有限公司 用于治疗及抗击结核病的方法和组合物
CN113101053A (zh) * 2021-03-30 2021-07-13 上海健康医学院 一种可释放一氧化氮的创伤敷料

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833438A7 (fi) 1982-10-26 1984-04-27 Kennecott Corp Tvao varmvalsar med hoeg hastighet, foerfarande och en smal remsprodukt
EP0139127A1 (en) * 1983-08-22 1985-05-02 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Transdermal drug delivery device and its preparation
JP2002521526A (ja) 1998-07-31 2002-07-16 ファースト ウォーター リミテッド 疎水性ポリマーを含む生体接着剤組成物
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
CA2323382C (en) 2000-10-17 2004-04-13 Pharma Mag Inc. Wound dressing
GB0715556D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
GB0715554D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20100055161A1 (en) 2008-08-27 2010-03-04 Dong June Ahn Hydrogel face mask for delivering skin care agents
ES2633618T3 (es) * 2009-10-14 2017-09-22 Theravasc Inc. Formulaciones farmacéuticas de nitrito y sus usos
WO2011076216A2 (en) 2009-12-22 2011-06-30 Rigshospitalet, Copenhagen University Hospital Wound care products
GB201309091D0 (en) * 2013-05-20 2013-07-03 Edixomed Ltd Dressing system

Similar Documents

Publication Publication Date Title
JP2016518458A5 (cg-RX-API-DMAC7.html)
JP2016522829A5 (cg-RX-API-DMAC7.html)
SI2908873T1 (en) TRANSDERMAL SYSTEM FOR DELIVERY
HRP20180275T1 (hr) Sustav zavoja
JP2017178948A5 (cg-RX-API-DMAC7.html)
CL2012003470A1 (es) Una composicion solida que comprende 1) un compuesto inhibidor del hcv de formula definida, o una sal farmaceuticamente aceptable de este, en una forma amorfa, 2) un polimero hidrofilico, y opcionalmente 3) un agente tensoactivo; su proceso de preparacion, util para tratar una infeccion del hcv.
AR070863A1 (es) Preparacion solida de desintegracion oral y metodo para suprimir la ruptura de los granulos finos durante la produccion de un comprimido
CL2011001817A1 (es) Forma de dosificacion unitaria solida oral en forma de tableta que comprende un nucleo y un recubrimiento externo, en donde el nucleo comprende alisquireno o a una sal del mismo, y el recubrimiento en un recubrimiento de pelicula, util para el tratamiento de una enfermedad o condicion en una poblacion pediatrica.
NZ713615A (en) Methods for treating bacterial infections
MX2015012760A (es) Composicion farmaceutica que comprende un activador de ampk y un agente serotonergico y metodos de uso de la misma.
JP2016518337A5 (cg-RX-API-DMAC7.html)
JP2018511410A5 (cg-RX-API-DMAC7.html)
WO2015187542A8 (en) Histone deacetylase inhibitors and compositions and methods of use thereof
RU2009122281A (ru) Средство для лечения заболеваний в ветеринарии на основе соли фосфония
JP2014148552A5 (cg-RX-API-DMAC7.html)
RU139546U1 (ru) Медицинская маска
PH12018501624A1 (en) A composition comprising pic for treatment of cancer
JP2017531030A5 (cg-RX-API-DMAC7.html)
CO2021002721A2 (es) Suspensiones líquidas de paracetamol
CN103156730A (zh) 异种脱细胞真皮基质护创系统
RU2013136780A (ru) Фармацевтическая композиция для лечения рака
PE20151282A1 (es) Combinacion de medicamentos que comprenden fenilefrina y paracetamol
CN103622782B (zh) 生物膜护创系统
CN204379821U (zh) 一种口腔溃疡膜贴片
RU2020121929A (ru) Фармацевтические комбинации